Bring Your Toughest AM Quality Problem To Formnext: Amsight Challenges Manufacturers To Rethink Production Quality 
Mentionkit Publishes SourcetoMCP Case Study on Social Listening for B2B SaaS Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scientific Advisory Board
Houston, Texas, USA, March 09, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston, Texas, a…
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
Roth Capital Partners has initiated research coverage on 22nd Century Group. BUFFALO, N.Y., March 09,…
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Metastatic Head and Neck Cancer
ROCHESTER, N.Y., March 09, 2022 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology…
Portage Biotech Announces Presentation of PORT-5 (STI-001) Late-Breaking Data at AACR 2022 Annual Meeting
Preclinical data will be presented in a late-breaking abstract session WESTPORT, Conn., March 09, 2022…
Fortress Biotech to Participate in Three March 2022 Investor Conferences
MIAMI, March 09, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual Meeting
Company to Present Adhesions Prevention Data on Wednesday, March 16, 2022, at 8:30 a.m. ET…
Assertio Reports Fourth Quarter and Full Year 2021 Financial Results
$32.2 Million Fourth Quarter Net Product Sales, a 7% Increase from Fourth Quarter 2020 and $109.4…
Journey Medical Corporation to Present at the 34th Annual ROTH Conference
SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM),…
Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada
HALIFAX, Nova Scotia, March 09, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR)…
Prelude Therapeutics Provides Clinical Update and Announces Presentation of New Preclinical Data at the Upcoming 2022 AACR Annual Meeting
Announces strategic prioritization within lead programs targeting PRMT5 and MCL1 Describes new pipeline candidate, PRT3645,…
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer
Dr. Siddhartha Kadia, CEO of Berkeley Lights “I am honored to lead the talented Berkeley…
Ayala Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conference
REHOVOT, Israel and WILMINGTON, Del., March 09, 2022 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq:…
Araris Biotech AG to Present Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2022
ZURICH, Switzerland, March 09, 2022 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering a…
Frontier Medicines Announces Oral Presentation on Dual-Acting Inhibitors of the Active and Inactive Forms of KRAS G12C at the American Association for Cancer Research (AACR) Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
Medexus to Participate in the 34th Annual Roth Conference
TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the…
Dyve Biosciences to Present at the 34th Annual Roth Conference
CAMARILLO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…
Running for Research – Prader-Willi Syndrome to Fund Multi-Center Study of DCCR in Early Phase Prader-Willi Syndrome
REDWOOD CITY, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2021 Financial Results
FLORHAM PARK, N.J., March 09, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…